Cargando…
Quality of life in ICU survivors with severe sepsis who received activated protein C
Autores principales: | Cook, WT, Eddleston, JM, Conway, D, Streets, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301468/ http://dx.doi.org/10.1186/cc1912 |
Ejemplares similares
-
The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999) -
Time-dependence of dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEAS), and cortisol in survivors and non-survivors of severe sepsis
por: Marx, C, et al.
Publicado: (2002) -
An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003) -
Haematological malignancy on the ICU - can we identify survivors?
por: Shah, S, et al.
Publicado: (2001) -
SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997)